批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2017/09/22 |
SUPPL-54(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/11/09 |
SUPPL-53(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2016/03/03 |
SUPPL-51(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2016/02/12 |
SUPPL-50(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2015/02/03 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/02/25 |
SUPPL-47(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2012/06/05 |
SUPPL-46(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/09/08 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/01/29 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/07/26 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/01/18 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/01/17 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/01/10 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/04/17 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/10/05 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/09/28 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/06/16 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/06/16 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/04/12 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/04/04 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2000/03/13 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/08/18 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/06/17 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/06/02 |
SUPPL-11(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
1998/09/23 |
SUPPL-4(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
1998/03/12 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1998/02/05 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/08/18 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1997/04/22 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/12/26 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/08/15 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:ALBUTEROL SULFATE 剂型/给药途径:AEROSOL, METERED;INHALATION 规格:EQ 0.09MG BASE/INH 治疗等效代码:AB1
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020503 |
001 |
NDA |
PROVENTIL-HFA |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
Yes |
Yes |
AB1 |
1996/08/15
|
KINDEVA |
209959 |
001 |
ANDA |
ALBUTEROL SULFATE |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
No |
No |
AB1 |
2020/04/08
|
CIPLA |
207085 |
001 |
ANDA |
ALBUTEROL SULFATE |
ALBUTEROL SULFATE |
AEROSOL, METERED;INHALATION |
EQ 0.09MG BASE/INH |
Prescription |
No |
No |
AB1 |
2021/06/01
|
SANDOZ |